Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antihypertensive drugs >  Aliskiren

Aliskiren

Basic information Safety Supplier Related

Aliskiren Basic information

Product Name:
Aliskiren
Synonyms:
  • Aliskiren
  • (aS,S,dS,zS)-d-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)--hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,z-bis(1-methylethyl)benzeneoctanamide
  • CGP 60536
  • CGP60536B
  • Rasilez
  • SPP 100
  • Tekturna
  • (aS,S,dS,zS)-d-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)--hydroxy-4-methoxy-3-(3-methoxypropoxy)-a,z-bis(1-methylethyl)benzeneoctanamide
CAS:
173334-57-1
MF:
C30H53N3O6
MW:
551.76
EINECS:
605-672-4
Product Categories:
  • API
  • Amines
  • Chemical Amines
  • Chiral Reagents
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Aliskiren intermediates
Mol File:
173334-57-1.mol
More
Less

Aliskiren Chemical Properties

Melting point:
98-99 °C
Boiling point:
748.4±60.0 °C(Predicted)
Density 
1.067±0.06 g/cm3(Predicted)
storage temp. 
Inert atmosphere,Store in freezer, under -20°C
solubility 
DMSO : 100 mg/mL (181.24 mM; Need ultrasonic)
form 
Powder
pka
9.49(at 25℃)
CAS DataBase Reference
173334-57-1(CAS DataBase Reference)
More
Less

Safety Information

Hazardous Substances Data
173334-57-1(Hazardous Substances Data)
More
Less

Aliskiren Usage And Synthesis

Description

Aliskiren is a first-in-class antihypertensive drug that acts by direct inhibition of renin. It is indicated for oral administration either as monotherapy or in combination with other antihypertensive agents. Renin catalyzes the cleavage of angiotensin to form angiotensin I, the first and the rate-limiting step of the RAAS. The inhibition of renin by aliskiren results in reduced levels of angiotensin I, angiotensin II, and aldosterone, all of which contribute to the antihypertensive effect. RAAS modulators are among some of the most commonly prescribed antihypertensive agents to date.The most common side effect of aliskiren is diarrhea, particularly with doses higher than 300mg daily. Unlike ACE inhibition, direct inhibition of renin does not increase bradykinin levels. Elevated bradykinin levels are thought to be responsible for the angioderma and cough that occur commonly during treatment with ACE inhibitors. .

Originator

Novartis (Switzerland)

Uses

An orally active, synthetic nonpeptide renin inhibitor. Antihypertensive

Uses

liquid crystal intermediate

Definition

ChEBI: A monomethoxybenzene compound having a 3-methoxypropoxy group at the 2-position and a multi-substituted branched alkyl substituent at the 4-position.

brand name

Tekturna

General Description

Aliskiren, (2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2-methyl-propyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-propan-2-yl-nonanamide (Tekturna), is the first renin inhibitorintroduced into the U. S. market. It was approved by theFDA in 2007 for the management of hypertension.The trade name for aliskiren in the United Kingdom isRasilez.

AliskirenSupplier

Changzhou Red Sun Pharmaceutical Co., Ltd. Gold
Tel
0519-85223897 13766960291
Email
zjc@czredsunpharm.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
China Langchem Inc.
Tel
0086-21-58956006
Shanghai Holy Biohemdeviser Co., Ltd
Tel
021-61551100